Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Austin
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Austin, TX

Studies commonly pay $75 to $4,500 per completed study

738 clinical trials are currently recruiting participants within 30 miles of Austin. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

738studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Austin right now

Top 25 of 738 recruiting studies, sorted by proximity — each links to its official registry page

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Phase 1 Interventional 694 participants sought
NEXT Oncology Austin /ID# 243005 — Austin, Texas (2.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05005403)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Dell Children's Medical Center of Central Texas — Austin, Texas (2.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

Any Solid Oral Medication N/A Interventional 200 participants sought
Texas Oncology — Austin, Texas (2.4 mi) · Sponsor: Dosentrx Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06344416)

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known N/A Interventional 1,000 participants sought
Austin Urology Institute — Austin, Texas (2.4 mi) · Sponsor: Pacific Edge Limited
See eligibility & contact on ClinicalTrials.gov (NCT06394869)

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Texas Oncology- Austin — Austin, Texas (2.4 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06773910)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Austin, Texas (2.4 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Austin, Texas (2.4 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT06999187)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Texas Diabetes & Endocrinology — Austin, Texas (2.4 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Austin Clinical Research, LLC — Austin, Texas (2.4 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

Ventricular Tachycardia (VT) N/A Interventional 60 participants sought
Texas Cardiac Arrhythmia Research Foundation — Austin, Texas (2.4 mi) · Sponsor: Medtronic Cardiac Ablation Solutions
See eligibility & contact on ClinicalTrials.gov (NCT06703489)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Texas Oncology - Central/South Texas ( Site 8006) — Austin, Texas (2.4 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Texas Oncology Central/South — Austin, Texas (2.4 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Austin, Texas (2.4 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
USO-Texas Oncology-Central/South Texas — Austin, Texas (2.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Austin Retina Associates — Austin, Texas (2.4 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10015 Austin, TX Investigational Site — Austin, Texas (2.4 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577 — Austin, Texas (2.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06810505)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
Texas Oncology - Austin Central /ID# 275046 — Austin, Texas (2.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06890338)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Austin, Texas (2.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)
Actively enrolling

Studies you may be able to join near Austin

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Austin

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Central Texas Clinical Research

★ 4.9 (13 reviews)
900 E 30th St #302, Austin, TX 78705
(512) 480-9660

Premier Research Group

★ 4.0 (1 reviews)
3200 Red River St #301, Austin, TX 78705
(800) 320-1630

PPD - Austin Research Unit

★ 3.5 (268 reviews)
7551 Metro Center Dr, Austin, TX 78744
(877) 773-3707
"Love this place food is good , the stuff and the dr super friendly Idont know why people complaining!!!"
— Laila Khan, 5★

UT Austin Texas Center for Health Outcomes Research & Education (TxCORE)

Pharmacy Building, 2409 University Ave Ste 3.210B, Austin, TX 78712
(512) 471-6892

Tekton Research

★ 4.4 (132 reviews)
4534 West Gate Blvd #110, Austin, TX 78745
(512) 388-5717
"The staff was friendly and helpful. The place is clean and well organized. All the information is explained completely."
— Rosemary McKnight, 5★

Addiction Research Institute

3001 Lake Austin Blvd, Austin, TX 78703

Elligo Clinical Research Center

★ 5.0 (2 reviews)
3508 S Lamar Blvd #300, Austin, TX 78704
(512) 989-5959
"I've had a great experience with Elligo Health Research! They offer a variety of clinical trials, which is a great way to contribute to medical resea…"
— Cassandra “Cass” Robinson, 5★

Optimal Research Austin, TX

★ 4.2 (16 reviews)
7551 Metro Center Dr Ste 200, Austin, TX 78744
(512) 320-0211
"I'm so glad I signed up for the Moderna Covid vaccination study. I lucked out and got the real vaccine 6 months ahead of the general public and got p…"
— Delwin Goss, 5★

UT Austin Children's Research Center

Sarah M. & Charles E. Seay Bldg, 108 E Dean Keeton St, Austin, TX 78712
(512) 471-6261

Clinical trials in Austin: what's recruiting

The Austin area currently has 738 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Austin, the most active research areas are:

  • Cancer & Oncology14 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Austin, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Austin

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Austin participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Austin pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Austin?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Austin, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Austin?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Austin.

Paid clinical trials near Austin

Other metros within reach

Killeen, TX105 San Antonio, TX1,010 Waco, TX53 College Station, TX46 Houston, TX3,069 Arlington, TX1,871 Grand Prairie, TX1,956 Fort Worth, TX609

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Austin Bladder Issues Due To Spinal Cord Injury in Austin All conditions

More of TX

Houston3,069 Pasadena3,010 Irving1,988 Grand Prairie1,956 Arlington1,871 Dallas1,868 Garland1,830 Plano1,825 Frisco1,824 Mesquite1,771 San Antonio1,010

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts